- Home
- EOS vs ARDX Comparison
EOS vs ARDX Comparison
Compare EOS & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOS
- ARDX
- Stock Information
- Founded
- EOS 2005
- ARDX 2007
- Country
- EOS United States
- ARDX United States
- Employees
- EOS N/A
- ARDX N/A
- Industry
- EOS Trusts Except Educational Religious and Charitable
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- EOS Finance
- ARDX Health Care
- Exchange
- EOS Nasdaq
- ARDX Nasdaq
- Market Cap
- EOS 1.2B
- ARDX 1.4B
- IPO Year
- EOS N/A
- ARDX 2014
- Fundamental
- Price
- EOS $22.73
- ARDX $4.97
- Analyst Decision
- EOS
- ARDX Buy
- Analyst Count
- EOS 0
- ARDX 7
- Target Price
- EOS N/A
- ARDX $11.75
- AVG Volume (30 Days)
- EOS 84.1K
- ARDX 5.5M
- Earning Date
- EOS 01-01-0001
- ARDX 10-31-2024
- Dividend Yield
- EOS 6.80%
- ARDX N/A
- EPS Growth
- EOS N/A
- ARDX N/A
- EPS
- EOS N/A
- ARDX N/A
- Revenue
- EOS N/A
- ARDX $251,849,000.00
- Revenue This Year
- EOS N/A
- ARDX $167.24
- Revenue Next Year
- EOS N/A
- ARDX $18.93
- P/E Ratio
- EOS N/A
- ARDX N/A
- Revenue Growth
- EOS N/A
- ARDX 87.57
- 52 Week Low
- EOS $15.62
- ARDX $4.01
- 52 Week High
- EOS $20.63
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- EOS 56.76
- ARDX 40.39
- Support Level
- EOS $22.85
- ARDX $4.43
- Resistance Level
- EOS $23.25
- ARDX $6.53
- Average True Range (ATR)
- EOS 0.26
- ARDX 0.42
- MACD
- EOS 0.01
- ARDX -0.12
- Stochastic Oscillator
- EOS 58.33
- ARDX 28.73
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. It invests in a portfolio of large and mid-cap securities in the sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.